OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,149 | – | 3,254 | +2462.2% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 127 | -99.2% | 0.00% | -100.0% |
| Q4 2021 | $105,000 | +138.6% | 15,108 | +379.5% | 0.01% | +200.0% |
| Q2 2021 | $44,000 | +131.6% | 3,151 | +162.6% | 0.00% | +50.0% |
| Q1 2021 | $19,000 | -62.0% | 1,200 | -51.1% | 0.00% | -60.0% |
| Q4 2020 | $50,000 | +56.2% | 2,454 | -42.7% | 0.01% | +25.0% |
| Q3 2020 | $32,000 | -23.8% | 4,282 | -16.9% | 0.00% | -33.3% |
| Q2 2020 | $42,000 | +740.0% | 5,152 | +288.0% | 0.01% | – |
| Q4 2017 | $5,000 | -54.5% | 1,328 | -31.1% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | -26.7% | 1,928 | +13.6% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -40.0% | 1,697 | -38.8% | 0.00% | -66.7% |
| Q1 2017 | $25,000 | +4.2% | 2,772 | -6.4% | 0.00% | 0.0% |
| Q4 2016 | $24,000 | – | 2,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |